519 related articles for article (PubMed ID: 17900512)
1. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
[TBL] [Abstract][Full Text] [Related]
2. [Initial experience with use of cationic propyl gallate as an inducer of thrombocyte aggregation in evaluation of anti-aggregation therapy].
Petrzelová A; Stejskal D; Prosková J; Oral I; Dostálová S; Lacnák B; Sebecková I; Horalík D; Zapletalová J; Bartek J; Vecerová H
Vnitr Lek; 2001 Nov; 47(11):747-52. PubMed ID: 11795179
[TBL] [Abstract][Full Text] [Related]
3. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
[TBL] [Abstract][Full Text] [Related]
4. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
[TBL] [Abstract][Full Text] [Related]
5. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
6. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
7. Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up.
Stejskal D; Václavík J; Lacnák B; Prosková J
Eur J Intern Med; 2006 Aug; 17(5):349-54. PubMed ID: 16864011
[TBL] [Abstract][Full Text] [Related]
8. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
[TBL] [Abstract][Full Text] [Related]
11. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
[TBL] [Abstract][Full Text] [Related]
12. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
[TBL] [Abstract][Full Text] [Related]
13. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
14. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
16. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Fox SC; May JA; Shah A; Neubert U; Heptinstall S
Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
[TBL] [Abstract][Full Text] [Related]
17. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Pongrácz E
Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
19. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
[TBL] [Abstract][Full Text] [Related]
20. Application of cationic propyl gallate as inducer of thrombocyte aggregation for evaluation of effectiveness of antiaggregation therapy.
Stejskal D; Prosková J; Petrzelová A; Bartek J; Oral I; Lacnák B; Horalík D; Sekaninová S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Dec; 145(2):69-74. PubMed ID: 12426775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
